GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

SynAct Pharma SYNACT.ST · SEK

Health Care · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

15.28

0.00%

Close of 9 Nov 2026, in SEK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price targets

Brokers' own targets, 21 Feb 2026. Not our view.

Average target 30.60

Low
30.30
Average
30.60
Median
30.60
High
31.50

Forecasts

Analyst averages for the fiscal years ahead

FY2026FY2027FY2028
RevenueSEK 44.3mSEK 21.6mSEK 77.9m
Revenue, highestSEK 88.5mSEK 43.2mSEK 77.9m
Revenue, lowest——SEK 77.9m
Earnings per share-1.68-0.98—
Earnings per share, highest-1.68-0.98—
Earnings per share, lowest-1.68-0.98—
Analysts221

Earnings against forecasts

Earnings per share by fiscal quarter

Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023
Forecast-0.38-0.21-0.21-0.35-0.75
Reported-0.44-0.50-0.47-0.69-2.58
Difference-16.8%-140.3%-125.9%-100.0%-242.6%

Quality and value scores

Models run by our data supplier, not our view and not investment advice

Model

Quality score

3 / 10

Revenue growth 0.0% a year over 10 years. Return on equity -65.1%.

Model fair value

18.05

From earnings —, from revenue 18.05.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.